These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
115 related items for PubMed ID: 35866835
21. Relationship between elevated plasma trimethylamine N-oxide levels and increased stroke injury. Wu C, Xue F, Lian Y, Zhang J, Wu D, Xie N, Chang W, Chen F, Wang L, Wei W, Yang K, Zhao W, Wu L, Song H, Ma Q, Ji X. Neurology; 2020 Feb 18; 94(7):e667-e677. PubMed ID: 31907287 [Abstract] [Full Text] [Related]
26. The Relationship of Large-Artery Atherothrombotic Stroke with Plasma Trimethylamine N-Oxide Level and Blood Lipid-Related Indices: A Cross-Sectional Comparative Study. Xu D, Zhao W, Song J, Yin L, Wang K, Wei L, Xu Y, Li H, Min B, Tang N, Jiang X, Liu H, Yan S, Leng H, Xue Q, Peng M, Wang H. Biomed Res Int; 2021 Feb 18; 2021():5549796. PubMed ID: 33977104 [Abstract] [Full Text] [Related]
27. Association of plasma trimethylamine-N-oxide levels with post-stroke cognitive impairment: a 1-year longitudinal study. Zhu C, Li G, Lv Z, Li J, Wang X, Kang J, Zhan C. Neurol Sci; 2020 Jan 18; 41(1):57-63. PubMed ID: 31420758 [Abstract] [Full Text] [Related]
29. Gut microbiota-derived trimethylamine N-oxide is associated with poor prognosis in patients with heart failure. Li W, Huang A, Zhu H, Liu X, Huang X, Huang Y, Cai X, Lu J, Huang Y. Med J Aust; 2020 Oct 18; 213(8):374-379. PubMed ID: 32959366 [Abstract] [Full Text] [Related]
30. Gut microbial metabolite TMAO portends prognosis in acute ischemic stroke. Zhang J, Wang L, Cai J, Lei A, Liu C, Lin R, Jia L, Fu Y. J Neuroimmunol; 2021 May 15; 354():577526. PubMed ID: 33647820 [Abstract] [Full Text] [Related]
31. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Tang WH, Wang Z, Kennedy DJ, Wu Y, Buffa JA, Agatisa-Boyle B, Li XS, Levison BS, Hazen SL. Circ Res; 2015 Jan 30; 116(3):448-55. PubMed ID: 25599331 [Abstract] [Full Text] [Related]
34. TMAO as a biomarker of cardiovascular events: a systematic review and meta-analysis. Guasti L, Galliazzo S, Molaro M, Visconti E, Pennella B, Gaudio GV, Lupi A, Grandi AM, Squizzato A. Intern Emerg Med; 2021 Jan 30; 16(1):201-207. PubMed ID: 32779113 [Abstract] [Full Text] [Related]
35. Gut microbiota-derived metabolite trimethylamine N-oxide as a biomarker in early Parkinson's disease. Chung SJ, Rim JH, Ji D, Lee S, Yoo HS, Jung JH, Baik K, Choi Y, Ye BS, Sohn YH, Yun M, Lee SG, Lee PH. Nutrition; 2021 Mar 30; 83():111090. PubMed ID: 33418492 [Abstract] [Full Text] [Related]
36. Longitudinal Plasma Measures of Trimethylamine N-Oxide and Risk of Atherosclerotic Cardiovascular Disease Events in Community-Based Older Adults. Lee Y, Nemet I, Wang Z, Lai HTM, de Oliveira Otto MC, Lemaitre RN, Fretts AM, Sotoodehnia N, Budoff M, DiDonato JA, McKnight B, Tang WHW, Psaty BM, Siscovick DS, Hazen SL, Mozaffarian D. J Am Heart Assoc; 2021 Sep 07; 10(17):e020646. PubMed ID: 34398665 [Abstract] [Full Text] [Related]
37. Serum levels of Trimethylamine-N-oxide in patients with ischemic stroke. Rexidamu M, Li H, Jin H, Huang J. Biosci Rep; 2019 Jun 28; 39(6):. PubMed ID: 31142624 [Abstract] [Full Text] [Related]
40. Trimethylamine N-oxide and risk of inflammatory bowel disease: A Mendelian randomization study. Banno Y, Nomura M, Hara R, Asami M, Tanaka K, Mukai Y, Tomata Y. Medicine (Baltimore); 2023 Aug 25; 102(34):e34758. PubMed ID: 37653747 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]